butabarbital decreases consequences of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Intently. Coadministration of CYP3A4 inducers might lessen sufentanil ranges and efficacy, potentially precipitating withdrawal syndrome in clients who definit